Blog

Novagen collaborates with stem cell firm – Seeking Alpha

Seeking Alpha
Early stage research by the firms point to the effectiveness of SBPs in normalizing stem cells associated with some types of neurodegeneration and muscular dystrophy. Novagen CEO Dr. Graham Kelly says that SBPs are known to be effective in killing
Novogen Announces Partnership with Genea Biocellsirasia.com (press release)

all 4 news articles

…read more    

2014-05-02 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.